Farmacia Hospitalaria y Farmacogenómica

Perez-Granda, MJ; Alonso, B; Rodriguez-Huerta, A; Rodriguez, C; Guembe, M.

In vitro assessment of the anti-biofilm activity of ethanol alone and in combination with enoxaparin 60 IU

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36(10): 627-632 Nº de citas: 1 [doi:10.1016/j.eimc.2017.11.007]

Romero-Jimenez, RM; Escudero-Vilaplana, V; Baniandres Rodriguez O; Garcia Martin E; Mateos Mayo A; Sanjurjo Saez M.

Association between clinical factors and dose modification strategies in the treatment with ustekinumab for moderate-to-severe plaque psoriasis

JOURNAL OF DERMATOLOGICAL TREATMENT. 2018; 29(8): 792-796 Nº de citas: 12 [doi:10.1080/09546634.2018.1466978]

Gonzalez-Hada-Pena, E; Manrique-Rodriguez, S; Herranz-Alonso, AM; Iglesias-Peinado, I; Sanjurjo-Sáez M.

A comparative study of contamination in three closed systems for the preparation of hazardous drugs through simulations with fluorescein

FARMACIA HOSPITALARIA. 2018; 42(6): 234-238 Nº de citas: 5 [doi:10.7399/fh.11024]

Osorio, S; Escudero-Vilaplana, V; Gomez-Centurion, I; Perez-Lopez, R; Ayala, R; Vall-Llovera, F; Garcia-Gutierrez, V; Casares, MTG; Miguel, JDGS; Hernandez-Rivas, JA; Sanchez-Guijo, F; Martinez-Garcia, AB; Villalon, L; Conesa-Garcia, V; Rodriguez, A; Casado, F; Garcia-Gonzalez, X; Perdomo, MNS; Banos, U; Steegmann, JL.

Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?

ANNALS OF HEMATOLOGY. 2018; 97(11): 2089-2098 Nº de citas: 20 [doi:10.1007/s00277-018-3413-7]

ALONSO FERNANDEZ, BEATRIZ; PEREZ GRANDA, MARIA JESUS; RODRÍGUEZ HUERTA, ANA MARÍA; RODRÍGUEZ GONZÁLEZ, CARMEN GUADALUPE; BOUZA SANTIAGO, EMILIO.

The optimal ethanol lock therapy regimen for treatment of biofilm-associated catheter infections: an in-vitro study

JOURNAL OF HOSPITAL INFECTION. 2018; 100(3): 187-195 Nº de citas: 11 [doi:10.1016/j.jhin.2018.04.007]

Salvador-Martin, S; Garcia-Gonzalez, X; Garcia, MI; Blanco, C; Garcia-Alfonso, P; Robles, L; Gravalos, C; Pachon, V; Longo, F; Martinez, V; Sanjurjo-Saez, M; Lopez-Fernandez, LA.

Clinical utility of ABCB1 for preventing toxicity in treatment with irinotecan

PHARMACOLOGICAL RESEARCH. 2018; 136: 133-139 Nº de citas: 19 [doi:10.1016/j.phrs.2018.08.026]

Collado-Borrell, R; Escudero-Vilaplana, V; Calles, A; Garcia-Martin, E; Marzal-Alfaro, B; Gonzalez-Haba, E; Herranz-Alonso, A; Sanjurjo-Saez, M.

Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey

JOURNAL OF MEDICAL INTERNET RESEARCH. 2018; 20(10): Nº de citas: 35 [doi:10.2196/11006]

Valerio, M; Vena, A; Rodriguez-Gonzalez, CG; de Vega, EC; Mateos, M; Sanjurjo, M; Bouza, E; Munoz, P.

Repeated antifungal use audits are essential for selecting the targets for intervention in antifungal stewardship

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2018; 37(10): 1993-2000 Nº de citas: 14 [doi:10.1007/s10096-018-3335-2]

Amor-Garcia, MA; Ibanez-Garcia, S; Diaz-Redondo, A; Alonso, AH; Saez, MS.

Multidisciplinary strategy to reduce errors with the use of medical gases

FARMACIA HOSPITALARIA. 2018; 42(3): 103-107 Nº de citas: 1 [doi:10.7399/fh.10920]

Marzal-Alfaro, MB; Barbero, MLM; Dominguez, JMG; Romero-Delgado, F; Gines, MLM; Herranz, A; Sanjurjo-Saez, M.

Impact of fampridine on quality of life: clinical benefit in real-world practice

EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2018; 25(3): 138-143 Nº de citas: 6 [doi:10.1136/ejhpharm-2016-001129]

Bouza, E; Valerio, M; Soriano, A; Morata, L; Carus, EG; Rodriguez-Gonzalez, C; Hidalgo-Tenorio, MC; Plata, A; Munoz, P; Vena, A.

Dalbavancin in the treatment of different gram-positive infections: a real-life experience

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2018; 51(4): 571-577 Nº de citas: 140 [doi:10.1016/j.ijantimicag.2017.11.008]

Escudero-Vilaplana, V; Osorio-Prendes, S; Collado-Borrell, R; Gonzalez-Arias, E; Sanjurjo-Saez, M.

Eosinophilia secondary to lenalidomide therapy

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2018; 43(2): 273-275 Nº de citas: 3 [doi:10.1111/jcpt.12611]

Crespo-Martinez, C; Sirvent-Ochando, M; Vazquez-Polo, A; Caba-Porras, I; Romero-Jimenez, RM; Telada-Gonzalez, P.

Survey on the use of zinc sulfate in parenteral nutrition in spanish hospitals

FARMACIA HOSPITALARIA. 2018; 42(2): 68-72 Nº de citas: 2 [doi:10.7399/fh.10855]

Fuentes-Irigoyen, R; Cabrera, AMMD; Riestra, AC; Vila, MN; Davila-Pousa, C; Herreros, JMA; Lopez-Cabezas, C; Canete, C; Pernia-Lopez, MS; Garcia-Palomo, M; Villalobos, PA; Ibares-Frias, L; Segura, JLU; Martinez, JRY.

Consensus SEO-SEFH of recommendations for use and compounding of ophthalmic preparations

FARMACIA HOSPITALARIA. 2018; 42(2): 82-88 Nº de citas: 4 [doi:10.7399/fh.10943]

López-Herce Cid J; Rodríguez Núñez A; Carrillo Álvarez Á; Zeballos Sarrato G; Martínez Fernández-Llamazares C; Calvo Macías C; Grupo Español de Reanimación Cardiopulmonar Pediátrica y Neonatal.

Recomendaciones de expertos sobre el material del carro y mochila de reanimacion cardiopulmonar pediatrica y neonatal.

ANALES DE PEDIATRIA. 2018; 88(3): [doi:10.1016/j.anpedi.2017.05.010]

Mañes-Sevilla M; Marzal-Alfaro MB; Romero Jiménez R; Herranz-Alonso A; Sanchez Fresneda MN; Benedi Gonzalez J; Sanjurjo-Sáez M.

Analisis modal de fallos y efectos para mejorar la calidad en los ensayos clinicos.

Journal Of Healthcare Quality Research. 2018; 33(1): 33-47 Nº de citas: 1 [doi:10.1016/j.cali.2017.12.001]

Galve-Calvo, E; Gonzalez-Haba, E; Gostkorzewicz, J; Martinez, I; Perez-Mitru, A.

Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2- advanced or metastatic breast cancer in Spain

ClinicoEconomics and Outcomes Research. 2018; 10: 773-790 Nº de citas: 20 [doi:10.2147/CEOR.S178934]

Garcia-Gonzalez, X; Lopez-Tarruella, S; Garcia, MI; Gonzalez-Haba, E; Blanco, C; Salvador-Martin, S; Jerez, Y; Thomas, F; Jarama, M; Saez, MS; Martin, M; Lopez-Fernandez, LA.

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

Cancer Management and Research. 2018; 10: 4517-4522 Nº de citas: 4 [doi:10.2147/CMAR.S174470]